IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients. (Q43845101)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 December 2012

Language	Label	Description	Also known as
English	IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients.	scientific article published on 20 December 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Salvador Resino

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

María Ángeles Jiménez-Sousa

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Norma I Rallón

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Vicente Soriano

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

María Guzmán-Fulgencio

4

object named as

M Guzmán-Fulgencio

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

J Berenguer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J C López

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

A Fernández-Rodríguez

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J Cosín

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

C Restrepo

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M García-Álvarez

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

P Miralles

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J M Benito

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

20 December 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

358-366

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Coinfection with HIV-1 and HCV--a one-two punch

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Management of chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Induction and function of type I and III interferon in response to viral infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Pharmacogenetics of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

A note on exact tests of Hardy-Weinberg equilibrium

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Hepatitis C pharmacogenetics: state of the art in 2010.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Redefining baseline demographics: the role of genetic testing in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12041

21 January 2018

Identifiers

10.1111/JVH.12041

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23565619%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43845101&oldid=2103827848"